arrow
L

Lydia López Manzanares

hospital universitario de la princesa
H指数:21
被引数:2,127

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy, safety, and tolerability of inhaled levodopa (CVT-301) across age, timing of motor fluctuations, and treatment initiation in Parkinson’s disease: Pooled analysis of three phase 3 trials

左旋多巴吸入剂(CVT-301)在帕金森病中的疗效、安全性和耐受性:针对年龄、运动波动时间和治疗起始时间的三项III期试验的合并分析

2026-11-100
PRE
Real-World Use of Opicapone in Management of Patients with Parkinson’s Disease and Early Motor Fluctuations in Spain: 12-Month Interim Analysis of REONPARK Study

在西班牙帕金森病伴早期运动波动患者中奥匹卡朋的实际应用与管理:REONPARK研究的12个月中期分析

2026-09-120
OA
Depression and Mood Changes in People with Parkinson’s Disease over Time: A 5-Year Follow-Up Study

帕金森病患者随时间推移的抑郁和情绪变化:一项为期5年的随访研究

2026-07-110
OA
Correction: López-Manzanares et al. Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson’s Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study. Brain Sci. 2025, 15, 532

更正:López-Manzanares等人。COMT抑制剂在西班牙帕金森病患者早期运动波动管理中的实际应用:REONPARK研究的初步结果。Brain Sci. 2025, 15, 532

2025-11-180
OAAI
Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial

基于可穿戴设备信息的帕金森病药物调整与其他方法比较:随机临床试验

2025-08-200
OA
Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline (vol 272, 246, 2025)

帕金森病-主观认知下降中认知进展的异质性与临床预测因子(卷272,246,2025)

2025-04-260
OA
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

基因靶向试验时代基因检测的相关性: 罗斯托克帕金森病研究

BRAIN
IF11.7
2024-08-018
OAAI
Suicidal ideation among people with Parkinson's disease and comparison with a control group
2023-05-052
PRE
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life
2023-03-066
OAAI
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson's Disease
2023-02-078
OAAI
Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness
2023-01-143
OAAI
Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints

伴有幻觉和主观认知不适的帕金森病患者认知功能障碍的风险

2023-01-012
OAAI
Trial of Prasinezumab in Early-Stage Parkinson's Disease

Prasinezumab在早期帕金森病中的试验

2022-08-04170
OA
Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients
2022-05-2710
OA
Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson's Disease Patients: A 2-Year Follow-Up Study
2022-05-056
OAAI
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
2022-01-2115
OA
Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
2021-12-216
OA